RELX’s LexisNexis Risk Solutions Deepens Epic Integration: New AI-Driven Identity Verification Enhances Healthcare Security
Expanded Identity Verification Suite Targets Seamless Security for US Hospitals
RELX (NYSE:RELX) subsidiary LexisNexis Risk Solutions is upping the ante for healthcare security, announcing on March 5th, 2026, its expanded partnership with Epic—one of the largest healthcare software providers in the US. This new move rolls out a broader identity verification suite, leveraging advanced AI and analytics to help hospitals balance regulatory risk, user experience, and the escalating threat of cybercrime.
Why This Matters: Cybersecurity and User Experience in Healthcare
Hospitals using Epic’s electronic health record (EHR) platform—including the widely used MyChart portal—can now choose from a robust menu of integrated verification tools. The rollout is designed to make verifying patient identities more flexibly configurable, helping providers reduce risk, improve compliance, and deliver a smoother, more secure process for patients logging in digitally.
Jonathan Shannon, LexisNexis’s AVP of healthcare strategy, called this "another step forward in instilling confidence and trust in healthcare organizations and patients alike." Amid ongoing cyber threats in healthcare, the ability to combine AI-powered solutions with workflow customization could be especially significant for hospitals looking to support digital access without compromise.
Key Solutions: AI-Powered Tools for Next-Gen Verification
| Solution | Core Functionality | Key Benefit |
|---|---|---|
| ThreatMetrix | AI-driven risk decision platform analyzing user behavior, device data, and transaction patterns | Distinguishes legitimate users from potential fraudsters |
| Instant Verify | Validates self-provided identity and professional credentials | Confirms user-provided information for higher onboarding trust |
| Flex ID | Delivers fast, data-driven verification insights to reduce registration friction | Lowers abandonment rates and accelerates customer onboarding |
| Phone Finder | Evaluates phone number trustworthiness using advanced metadata | Detects potential risk associated with phone identities |
| One Time Password | Sends unique passcodes for multi-factor authentication | Simple, reliable step-up authentication to strengthen security |
| IDVerse (upcoming) | Authenticates documents and biometrics to detect forgeries and deepfakes with AI | Future-proofs workflows against sophisticated fraud |
Industry Implications: A Step Forward for Trust and Compliance
Healthcare data breaches are surging, making robust but user-friendly access controls a top concern for hospitals and regulators alike. By offering modular, AI-driven identity tools that go beyond passwords and simple verification, LexisNexis and RELX could be setting a new security standard for electronic healthcare access. The coming addition of IDVerse—with its AI document and biometric checks—signals a continued evolution toward secure, frictionless authentication.
With Epic estimating that more than a third of the US population has a record in its systems, RELX’s expanded integration could influence patient security and privacy standards across the nation. Hospitals can adopt these features flexibly, selecting solutions that match their unique risk profiles and regulatory needs.
Takeaway: Eye on Patient Access, Security, and Future-Proofing
While this expansion won’t eliminate risk overnight, it introduces new options—and, potentially, new expectations—around digital trust in healthcare. Investors and industry watchers may want to keep an eye out for adoption momentum later this year, as RELX integrates IDVerse and further broadens its Epic partnership. The race for secure, patient-centric digital access continues, and RELX is clearly staking a leadership claim.
Contact Information:
If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.
About the Publisher - Marketchameleon.com:
Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.
NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.
The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.
Disclosure: This article was generated with the assistance of AI